Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s Disease

4 Jul 2015

Abstract excerpt

BACKGROUND: The composition of the intestinal microbiota is altered in Crohn's disease [CD] patients. The objective of this study was to evaluate the qualitative and quantitative changes in the microbiota of CD patients in 3 months of treatment with adalimumab [ADA], and determine whether or not these changes are produced towards the recovery of the normal, healthy-like microbiota. METHODS: The microbiota...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Inflammatory Bowel Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26142465
DOI: 10.1093/ecco-jcc/jjv119

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s DiseasePMID 26142465Read ↗

Dynamic Changes in the Gut Microbiota Composition during Adalimumab Therapy in Patients with Ulcerative Colitis: Implications for Treatment Response Prediction and Therapeutic TargetsSemantic proximity Read ↗

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relativesSemantic proximity Read ↗

Gut microbiota analysis for prediction of clinical relapse in Crohn’s diseaseSemantic proximity Read ↗

A distinctive 'microbial signature' in celiac pediatric patientsSemantic proximity Read ↗

Abnormal microbiota composition in the ileocolonic mucosa of Crohnʼs disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresisSemantic proximity Read ↗

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s DiseaseSemantic proximity Read ↗

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colonSemantic proximity Read ↗

Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease PatientsSemantic proximity Read ↗

The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease.Semantic proximity Read ↗

Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative ColitisSemantic proximity Read ↗

Fecal microbial composition of ulcerative colitis and Crohn's disease patients in remission and subsequent exacerbation.Semantic proximity Read ↗

Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.